Roche Diagnostics CORPORATION
UEI JDMDFEZBYH36 CAGE 51169 Active Indianapolis, IN
Other Than Small Business · Data through September 4, 2026
Obligations, FY2025
$75.1M
Total obligations, FY2023–FY2025
$331.5M
Contract actions, FY2023–FY2025
1,422
Top agency
Department of Defense
Obligations by fiscal year
| Fiscal year | Obligations |
|---|---|
| FY2026 (partial year) | $88.2M |
| FY2025 | $75.1M |
| FY2024 | $78.4M |
| FY2023 | $178.1M |
| FY2022 | $667.8M |
| FY2021 | $93.4M |
Agencies, NAICS, and PSC codes
| Agency | Obligations | Share |
|---|---|---|
| Department of Defense | $736.1M | 62.3% |
| Department of Veterans Affairs | $319.8M | 27.1% |
| Department of Health and Human Services | $116.7M | 9.9% |
| Department of Justice | $5.7M | 0.5% |
| Department of Agriculture | $2.5M | 0.2% |
| NAICS code | Obligations | Share |
|---|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $778.5M | 65.9% |
| 334516 — Analytical Laboratory Instrument Manufacturing | $361.8M | 30.6% |
| 622110 — General Medical and Surgical Hospitals | $23.2M | 2% |
| 811219 — Other Electronic and Precision Equipment Repair and Maintenance | $4.5M | 0.4% |
| 339112 — Surgical and Medical Instrument Manufacturing | $4.4M | 0.4% |
| PSC code | Obligations | Share |
|---|---|---|
| 6515 — Medical and Surgical Instruments, Equipment, and Supplies | $618.3M | 52.4% |
| 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | $220.6M | 18.7% |
| 6640 — Laboratory Equipment and Supplies | $179.3M | 15.2% |
| 6630 — Chemical Analysis Instruments | $90.3M | 7.6% |
| Q301 — Medical- Laboratory Testing | $14.8M | 1.2% |
Contract type and set-aside mix
| Contract pricing type | Obligations | Share |
|---|---|---|
| Firm Fixed Price | $1.18B | 100% |
| Set-aside type | Obligations | Share |
|---|---|---|
| No Set Aside Used. | $837.4M | 70.9% |
| Not Specified | $343.5M | 29.1% |
| Small Business Set Aside - Total | -$4K | 0% |
Place of performance by state
| State | Obligations | Share |
|---|---|---|
| IN | $972.8M | 82.4% |
| MD | $38.5M | 3.3% |
| TX | $27.7M | 2.3% |
| OH | $21.1M | 1.8% |
| WA | $13.9M | 1.2% |
| VA | $11.3M | 1% |
| NC | $10.1M | 0.9% |
| CA | $9.7M | 0.8% |
| GA | $9.3M | 0.8% |
| FL | $8.4M | 0.7% |
Largest contract actions on file
| Award | Agency | Period of performance | Obligation | Record |
|---|---|---|---|---|
| W58P0522C0010 · NAICS 325413 | Department of Defense | January 13, 2022 – March 14, 2022 | $340.0M | View on USAspending |
| W58P0522C0010 · NAICS 325413 | Department of Defense | January 13, 2022 – May 31, 2022 | $212.5M | View on USAspending |
| 75A50223C00008 · NAICS 325413 | Department of Health and Human Services | December 7, 2022 – March 30, 2023 | $90.6M | View on USAspending |
| W58P0522C0010 · NAICS 325413 | Department of Defense | January 13, 2022 – March 25, 2022 | $17.0M | View on USAspending |
| 36C26223N1049 · NAICS 334516 | Department of Veterans Affairs | September 29, 2023 – March 26, 2024 | $5.9M | View on USAspending |
| 36C24819F0302 · NAICS 334516 | Department of Veterans Affairs | June 1, 2019 – September 30, 2023 | $4.2M | View on USAspending |
| 36C24824F0003 · NAICS 334516 | Department of Veterans Affairs | October 1, 2023 – September 30, 2025 | $4.0M | View on USAspending |
| 36C24824F0003 · NAICS 334516 | Department of Veterans Affairs | October 1, 2023 – September 30, 2026 | $3.9M | View on USAspending |
| 36C24819F0302 · NAICS 334516 | Department of Veterans Affairs | June 1, 2019 – September 30, 2021 | $3.9M | View on USAspending |
| 36C24819F0302 · NAICS 334516 | Department of Veterans Affairs | June 1, 2019 – September 30, 2022 | $3.9M | View on USAspending |
Parent company
Roche Holding Ag (UEI WJHDT127L353)
Other UEIs under this parent
- Genentech Usa, INC — UEI SA85BMHCTXK5
Similar contractors
- Siemens Healthcare Diagnostics INC. — $895.6M, Tarrytown, NY
- Biomerieux INC — $185.1M, Salt Lake City, UT
- Biofire Diagnostics LLC — $92.7M, Salt Lake City, UT
- Abbott Rapid Dx North America LLC — $4.11B, Orlando, FL
What the numbers show
No transaction in this record used a small-business set-aside; all obligations were awarded with no set-aside or an unspecified type.
Obligations decreased from $78.4M in FY2024 to $75.1M in FY2025, the last closed fiscal year.
Source: USAspending.gov, U.S. Department of the Treasury. Contract transactions FY2021–FY2026, downloaded 2026-09-18. Figures are net obligations and can include de-obligations. Department of Defense data is published with a 90-day delay. View this contractor's largest contract on USAspending.gov.
To request removal of this profile, use the contact form and select "Removal request." Requests are processed within 30 days.